Since Willin/FRMD6 is necessary for the recruitment of aPKC to AJCs in order to regulate ROCK activation [3], downregulation of Willin/FRMD6 in AD may decrease the ability of aPKC to inhibit ROCK activation, exacerbating Aβ oligomers-induced BBB damage. Here, FRMD6 is linked to Alzheimer disease.